Evaluation of Fluid-Filled Expression Core Technology Study - I
Effect-1
1 other identifier
interventional
26
1 country
1
Brief Summary
A functional model of a fluid-filled, smaller dead volume breast pump has been developed in order to more closely mimic the breastfeeding infant. The technology of fluid-filled pumping has been tested in one prior clinical study and has now progressed to a complete prototype with which the user can assemble, pump, disassemble, clean and reuse.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2019
CompletedFirst Posted
Study publicly available on registry
April 19, 2019
CompletedStudy Start
First participant enrolled
May 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 7, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 7, 2019
CompletedFebruary 10, 2020
November 1, 2019
6 months
April 11, 2019
February 7, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Recording all Adverse Events
Recording all AE and evaluating the (time of) occurrence, type, seriousness, expectedness, relatedness, and outcome of the adverse events
3 months
Observing pump performance
Measuring milk flow volume including time to first ejection.
3 months
Secondary Outcomes (1)
Measureing user acceptance
3 months
Study Arms (1)
Evaluation of Fluid Expression Technology
OTHERThis study aims to provide important insights with respect to the safety, performance, and real-life usability of pumping technology
Interventions
Eligibility Criteria
You may qualify if:
- Subject ≥ 18 years old
- Infant is ≥1 and ≤6 month old
- Subject and baby are healthy according to self-declaration in the "Mother and infant health questionnaire"
- Subject is predominantly breastfeeding (80% of all feeds, i.e. ≤150 ml formula/day or equal representative amount of solid food)
- The subject agrees to pump or feed the last time a minimum of 2 hours (hr) before the start of the pumping session at the study site
- The subject agrees to photographs/3 D scan of the breast and upper body (no face),
- The subject agrees to a video while pumping
- The subject signs the informed consent documentation
- Subject agrees that a maximum of 2 male team members can be present in the room to conduct the usability part of the study
- The mother accepts that the pumped milk in visit 2 must be donated to the study i.e. cannot be fed to the baby
You may not qualify if:
- The subject has a nipple size ≥ 21 mm
- Mastitis (any breast within two weeks prior to enrolment)
- Engorgement (any breast within two weeks prior to enrolment).
- Case of current infection as self-declared in the Mother and infant health questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medela AGlead
Study Sites (1)
Medela AG
Baar, 6431, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Beatrix Mascher, MBA
Clinical Affairs within Medical Reseach and R&D
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2019
First Posted
April 19, 2019
Study Start
May 8, 2019
Primary Completion
November 7, 2019
Study Completion
November 7, 2019
Last Updated
February 10, 2020
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share